Article Figures & Data
Tables
Characteristic Male Female OR (CI) P-value n (%) Age 18- 30 years 21 (65.6) 20 (40.0) 2.86 (1.13-7.20) 0.02 More than 30 years 11 (34.4) 30 (60.0) Marital status Married 20 (62.5) 38 (76) 0.5 (0.20-1.3) 0.22 Single 12 (37.5) 12 (24) Education Illiterate 0 (0.0) 14 (28.0) 0.004 School 18 (56.2) 23 (46.0) University 14 (43.8) 13 (26.0) Occupation Non-working 2 (6.3) 43 (86.0) <0.001 Military 13 (40.5) 0 Other jobs 17 (53.2) 7 (14.0) Residence Urban 26 (81.2) 35 (70.0) 1.85 (0.63-5.43) 0.30 Rural 6 (18.8) 15 (30.0) Income /month <5000 SR 0 (0.0) 11 (22.0) 0.001 5000-10000SR 14 (43.8) 30 (60.0) 10000-20000SR 13 (40.6) 8 (16.0) ≥20000 SR 5 (15.6) 1 (2.0) BMI Normal 18 (56.2) 21 (42.0) 0.02 Overweight 14 (43.8) 19 (38.0) Obese 0 (0.0) 10 (20.0) Family history of MS Yes 2 (6.3) 2 (4) 1.61 (0.214-11.96) 0.64 No 30 (93.7) 48 (96) OR - Odds ratio, CI - confidence interval, SR - Saudi Riyals, BMI - body mass index, MS - multiple sclerosis.
Characteristic Ratio Mean±SD Range Gender Ratio Female 1.56 Male 1 Current age in years Total MS patients 34.57±9.48 18-56 Age at diagnosis Total MS patients 30.50±9.29 10-54 Male 26.90±7.7 10-44 Female 32.8±9.8 18-56 Disease duration (years) 4.07±3.65 <1-11 SD - standard deviation, MS - multiple sclerosis
Characteristic Males Females P-value n (%) Age at disease diagnosis Less than 18 2 (6.3) 0 (0.0) 0.003 18-30years 25 (78.1) 25 (50.0) More than 30 years 5 (15.6) 25 (50.0) Duration of disease Less than 1 year 4 (12.5) 9 (18.0) 0.89 1-5years 17 (53.1) 25 (50.0) 5-10 years 9 (28.1) 12 (24.0) More than 10 years 2 (6.3) 4 (8.0) Type of disease RRMS 22 (68.8) 31 (62.0) 0.889 RPMS 4 (12.5) 6 (12.0) SPMS 3 (9.4) 5 (10.0) PPMS 0 1 (2.0) CIS 3 (9.4) 7 (14.0) Symptoms at disease onset Optic 10 (31.3) 21 (42.0) 0.774 Spinal cord 9 (28.1) 11 (22.0) Cerebellar 8 (25.0) 10 (20.0) Sensory 5 (15.6) 7 (14.0) Brain stem 0 (0.0) 1 (2.0) Medication Used Betaferon (interferon beta-1b) 19 (59.3) 19 (36.0) 0.25 Rebif (interferon beta 1-a) 11 (34.4) 26 (52.0) Rebif+beta 2 (6.3) 2 (4.0) Rebif+Vit. D 0 2 (4.0) Tecfidera 0 1 (2.0) RRMS - relapsing remitting multiple sclerosis, RPMS - relapsing progressive multiple sclerosis, SPMS - secondary progressive multiple sclerosis, PPMS - primary progressive multiple sclerosis, CIS - clinically isolated syndrome.